No Detail Found!

Study on the mechanism of Yajieyixin formula in improving atherosclerosis

Author(s)
Shihua Luo Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Yunnan, China; The Affiliated Hospital of Yunnan University of Chinese Medicine China
Xiaoli Jiang Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine,Yunnan,China
Yi Li The Affiliated Hospital of Yunnan University of Chinese Medicine, China
Yan Gao The Affiliated Hospital of Yunnan University of Chinese Medicine, China
Xinhui He The Affiliated Hospital of Yunnan University of Chinese Medicine, China
Wanliu Zhang The Affiliated Hospital of Yunnan University of Chinese Medicine, China
Xijie Li The Affiliated Hospital of Yunnan University of Chinese Medicine, China
Yinfeng Chen The Affiliated Hospital of Yunnan University of Chinese Medicine, China
Xiaohua Duan Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine,Yunnan,China
Lijuan Zhao The Affiliated Hospital of Yunnan University of Chinese Medicine, China
Abstract
Yajieyixin Formula (YJYXF) is an effective prescription commonly used by Dai medicine practitioners to treat cardiovascular diseases. This study explored how YJYXF helps ApoE mice with atherosclerosis (AS). An atherosclerosis model was established by feeding ApoE mice with a high-fat diet, and treatment with 36.075 g/kg YJYXF and 12.025 g/kg YJYXF for 12 weeks were the optimal treatment conditions for the ankylosis spondylitis mouse model. The mechanism of action of YJYXF against atherosclerosis was comprehensively analyzed by observing the AS-related indexes (blood biochemical indexes, inflammation indexes, TMAO), changes in atherosclerotic plaques observed by HE staining and oil red O staining, liver metabolisms, microbiome, changes in bile acid content, and the expression of key genes and proteins of cholesterol metabolism. The present study showed that YJYXF could lower blood lipid levels, reduce inflammation and aortic plaque accumulation, regulate hepatic lipid metabolism, and regulate bile acid metabolism by modulating the diversity, composition and abundance of intestinal flora, and by decreasing the expression levels of intestinal FXR, FGF15 mRNA and protein, and by increasing the expression levels of hepatic CYP7A1 mRNA and protein. The study findings that YJYXF can improve AS, and the mechanism is associated with intestinal microbiota regulation by trimethylamine Noxide (TMAO).
Publication Details
Page(s) 1081-1094
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Atherosclerosis, Intestinal microbiota, Lipid metabolism, Yajieyixin formula, trimethylamine N-oxide
References
. .Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production. Gut., 73(12) : 1934-1943.
Ai J,Tang X,Mao B,Zhang Q,Zhao J,Chen W,Cui S W .2024 .Gut microbiota: A superior operator for dietary phytochemicals to improve atherosclerosis. Crit. Rev. Food Sci Nutr, : 1-23.
Bao M,Li H,Li J .2024 .Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease. BMC Cardiovasc Disord, 24 : 265.
Centner AM,Khalili L,Ukhanov V,Kadyan S,Nagpal R,Salazar G .2023 .The role of phytochemicals and gut microbiome in atherosclerosis in preclinical mouse models. Nutrients, 15(5) : 1212.
Chen ML,Yi L,Zhang Y,Zhou X,Ran L,Yang J,Zhu JD,Zhang QY,Mi MT .2016 .Resveratrol attenuates trimethylamine-n-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio, 7 : e02210-15.
Chi L,Yifeiyang Bian X,Gao B,Tu P,Ru H,Lu K H .2024 .Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions. Sci. Total Environ, 919 : 169603.
Depommier C,Everard A,Druart C,Plovier H,Van Hul M,Vieira-Silva S,Falony G,Raes J,Maiter D,Delzenne NM,De Barsy M,Loumaye A,Hermans MP,Thissen JP,De Vos,Cani PD .2019 .Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof of concept exploratory study. Nat. Med, 25 : 1096-1103.
Du Z,Zhao X,Sun L,Chi B,Ma Z,Tian Z,Liu Y,Chromatogr B. Analyt,Technol B. Analyt .2023 .Untargeted lipidomics-based study reveals the treatment mechanism of Qingxue Bawei tablets on atherosclerotic in ApoE(-/-) mice. , 1229 : 123889.
Fan L,Liu J,Hu W,Chen Z,Lan J,Zhang T,Zhang Y,Wu X,Zhong Z,Zhang D,Zhang J,Qin R,Chen H,Zong Y,Zhang J,Chen B,Jiang J,Cheng J,Zhou J,Gao Z,Liu Z,Chai Y,Fan J,Wu P,Chen Y,Zhu Y,Wang K,Yuan Y,Huang P,Zhang Y,Feng H,Song K,Zeng X,Zhu W,Hu X,Yin W,Chen W,Wang J .2024 .Targeting proinflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans. Cell Res, 34 : 407-427.
Fei SF,Hou C,Jia F C .2024 .Effects of salidroside on atherosclerosis: Potential contribution of gut microbiota. Front Pharmacol, 15 : 1400981.
Gillard KK,Bloedon L,Grady-Benson JC,Edwards A,Fahy S,Sasiela WJ,Louie MJ,Thompson PD .2024 .Prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease derived from United States administrative claims data. Cardiol. Ther., 13 : 575-591.
He Y,Zhu Y,Shui X,Huang Z,Li K,Lei W K,ApoE K .2024 .Gut microbiome and metabolomic profiles reveal the antiatherosclerotic effect of indole-3-carbinol in highcholine-. , 129 : 155621.
Huang T,Jiang J,Cao Y,Huang J,Zhang F,Cui G F .2023 .Camellia oil (Camellia oleifera Abel.) treatment improves high-fat diet-induced atherosclerosis in apolipoprotein E (ApoE)(-/-) mice. Biosci Microbiota Food Health, 42 : 56-64.
Huang Y,Xu W,Dong W,Chen G,Sun Y,Zeng X Y .2024 .Anti-diabetic effect of dicaffeoylquinic acids is associated with the modulation of gut microbiota and bile acid metabolism. J. Adv. Res., 72 : 17-35.
Ilyas I,Little PJ,Liu Z,Xu Y,Kamato D,Berk BC,Weng J,Xu S J .2022 .Mouse models of atherosclerosis in translational research. Trends Pharmacol Sci., 43 : 920-939.
Jiang S,Yu C,Lv B,He S,Zheng Y,Yang W,Wang B,Li D,Lin J .2023 .Two-sample Mendelian randomization to study the causal association between gut microbiota and atherosclerosis. Front Immunol, 14 : 1282072.
Kliewer SA,Mangelsdorf DJ SA .2015 .Bile Acids as Hormones: The FXR-FGF15/19 Pathway. , 33 : 327-331.
Li D,Zhang L,Dong F,Liu Y,Li N,Li H,Lei H,Hao F,Wang Y,Zhu Y,Tang H Y,Mice. J Proteome Y .2015 .Res. , 14 : 2237-54.
Luo Z,Yu X,Wang C,Zhao H,Wang X,Guan X .2024 .Trimethylamine N-oxide promotes oxidative stress and lipid accumulation in macrophage foam cells via the Nrf2/ABCA1 pathway. J. Physiol Biochem., 80 : 67-79.
Ma SR,Tong Q,Lin Y,Pan LB,Fu J,Peng R,Zhang XF,Zhao ZX,Li Y,Yu JB,Cong L,Han P,Zhang ZW,Yu H,Wang Y,Jiang JD Y .2022 .Berberine treats atherosclerosis via a vitamine-like effect downregulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduct Target Ther., 7 : 207.
Mao Y,Kong C,Zang T,You L,Wang LS,Shen L,Ge JB .2024 .Impact of the gut microbiome on atherosclerosis. mLife, 3 : 167-175.
Schoeler M and Caesar R .2019 .Dietary lipids, gut microbiota and lipid metabolism. Rev. Endocr. Metab, 20 : 461-472.
Sheng Y,Meng G,Zhang M,Chen X,Chai X,Yu H,Han L,Wang Q,Wang Y,Jiang M Y .2024 .Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway. J. Ethnopharmacol., 330 : 118209.
Sheng Y,Meng G,Zhou Z,Du R,Wang Y,Jiang M Y .2023 .PARP-1 inhibitor alleviates liver lipid accumulation of atherosclerosis via modulating bile acid metabolism and gut microbes. Mol Omics, 19 : 560-573.
Sobukawa Y,Hatta T,Funaki D,Nakatani E .2024 .Safety of combined statin and fibrate therapy: Risks of liver injury and acute kidney injury in a cohort study from the Shizuoka Kokuho database. Drugs Real World Outcomes, 11 : 317-330.
Song T,Chen WD .2021 .Berberine inhibited carotid atherosclerosis through PI3K/AKTmTOR signaling pathway. Bioengineered., 12 : 8135-8146.
Wan H,Lu Y,Yang J,Wan H,Yu L,Fang N,He Y,Li C Y .2024 .Naoxintong capsule remodels gut microbiota and ameliorates early-stage atherosclerosis in apolipoprotein E-deficient mice. Phytomedicine, 129 : 155662.
Wang C,Ma Q,Yu X .2023 .Bile acid network and vascular calcification-associated diseases: Unraveling the intricate connections and therapeutic potential. Clin Interv Aging, 18 : 1749-1767.
Wang F,Zhao C,Tian G,Wei X,Ma Z,Cui J,Wei R,Bao Y,Kong W,Zheng J .2020 .Naringin alleviates atherosclerosis in ApoE(-/-) mice by regulating cholesterol metabolism involved in gut microbiota remodeling. J Agric Food Chem, 68 : 12651-12660.
Wang H,Zhang L,Zhang X,Song J,Guo Q,Zhang X,Bai D X .2022 .Prediction model for different progressions of atherosclerosis in ApoE(-/-) mice based on lipidomics. J Pharm Biomed Anal, 214 : 114734.
Wang Y,Wu J,Hong Y,Zhu J,Zhang Y,Zhang J,Ding C,Che Y,Wang G,Jiang A,Hao H,Cao L H .2024 .Ginsenosides retard atherogenesis via remodelling hostmicrobiome metabolic homeostasis. Br. J. Pharmacol., 181 : 1768-1792.
Xu M,Lv C,Wang H,Lu Q,Ye M,Zhu X,Liu R X .2022 .Peanut skin extract ameliorates high-fat dietinduced atherosclerosis by regulating lipid metabolism, inflammation reaction and gut microbiota in ApoE(-. Food Res Int., 154 : 111014.
Yu J,Zhu Q,Zhou M,Huang X,Le Y,Ouyang H,Cheng S H .2024 .Mechanism of Tianma-Gouteng granules lowering blood pressure based on the bile acidregulated farnesoid X receptor-fibroblast growth factor 15- Cholesterol 7α-hydroxylase pathway. J Ethnopharmacol, 328 : 118091.
Zheng S,Liu Z,Liu H,Lim JY,Li DWH,Zhang S,Luo F,Wang X,Sun C,Tang R,Zheng W,Xie Q .2024 .Research development on gut microbiota and vulnerable atherosclerotic plaque. Heliyon, 10 : e25186.
Zhu J,Lyu J,Zhao R,Liu G,Wang S G .2023 .Gut macrobiotic and its metabolic pathways modulate cardiovascular disease. Front Microbiol, 14 : 1272479.
Zhuo X,Luo H,Lei R,Lou X,Bian J,Guo J,Luo H,Zhang X,Jiao Q,Gong W .2023 .Association between intestinal microecological changes and atherothrombosis. Microorganisms, 11(5) : 1223.
0

Citations

0

Downloads

116

Views